Canadian Cardiovascular Society grading of angina pectoris

Last updated

Canadian Cardiovascular Society grading of angina pectoris
Purposegrade the severity of exertional angina

The Canadian Cardiovascular Societygrading of angina pectoris (sometimes referred to as the CCS Angina Grading Scale or the CCS Functional Classification of Angina) is a classification system used to grade the severity of exertional angina.

Contents

Medical use

Relevance

The CCS grading system for angina is a clinical tool used by doctors to assess the degree of severity of a patient's angina. Whilst there are no defined therapy guidelines specific for each class, once the severity of the angina has been assessed, clinicians can use the framework to aid them in the development of an individual treatment plan. This will also depend on unique patient factors, such as age, and risk of major cardiac complications.[ citation needed ]

In low severity cases, treatment will primarily consist of lifestyle changes, such as exercise, change in diet, smoking cessation. Often, this will be supplemented with medication. [1]

For higher severity cases, this medication may need to be combined with surgery. For example percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG). Both PCI and CABG are effective at minimising symptoms and preventing progression of the symptoms. However, each therapy has its advantages and disadvantages when it comes to individual patient profile. [1] PCI is one of the most commonly performed procedures on the heart. It is non-surgical, and so can be carried out safely in most patient groups. [2] In high-risk patients, such as those over the age of 65, with diabetes, or with multi-vessel disorder, CABG may be the preferred technique. [3] Although it is more invasive, in this group of patients, CABG has a higher long-term survival rate compared to PCI. [4] [5]

Acceptance

The CCS grading system is widely adopted in medical literature, with 656 manuscripts citing this grading system as of 2002 (87% were written in English, 28% in German, 27% in Russian, 22% in French, 2% each in Scandinavian and Spanish, and 1% in Japanese). [6] The CCS grading system has also been described in at least 18 medical and nursing textbooks. [6] Increasing CCSA class was associated with increased long-term mortality, even after adjusting for baseline characteristics (P<0.01). Eight-year mortality rates were 20.5%, 24.1%, 40.4% and 35.3% among class I, II, III and IV patients, respectively. Limitations of the CCS grading system include the lack of consideration of confounding factors, such as drug therapy before exertion (particularly sublingual nitrates), and personal warm-up. [6] The rate of worsening angina significantly also increased with increasing CCS class from I to III. [7]

Evaluation of fitness to fly

The CCS grading system for angina is, in part, used to evaluate fitness to fly by the British Cardiovascular Society. They recommend no action by class I and II patients with stable angina, class III should consider mobility assistance from airport staff and in-flight supplemental oxygen therapy, and that class IV patients should ideally defer their travel plans or travel with a medical chaperone and use supplemental oxygen in-flight. [8]

Functional classification

CCS grading of Angina pectoris [9]
ClassDescription of Angina severity
0Asymptomatic Angina [10] Mild myocardial ischemia with no symptoms.
IAngina only with strenuous exertionPresence of angina during strenuous, rapid, or prolonged ordinary activity (walking or climbing the stairs).
IIAngina with moderate exertionSlight limitation of ordinary activities when they are performed rapidly, after meals, in cold, in wind, under emotional stress, during the first few hours after waking up, but also walking uphill, climbing more than one flight of ordinary stairs at a normal pace and in normal conditions.
IIIAngina with mild exertionHaving difficulties walking one or two blocks or climbing one flight of stairs at normal pace and conditions.
IVAngina at restNo exertion needed to trigger angina.

(Note: Class 0 is not an official part of the CCS functional classification of angina pectoris, however it has been mentioned in several sources, referring to myocardial ischemia without symptoms.)

History

Canadian Cardiovascular Society (CCS) is a national collaboration between cardiovascular clinicians and scientists, promoting cardiovascular health and care excellence through knowledge translation (dissemination of research and application of best practices), professional development, and leadership. [11] The CCS developed the angina pectoris grading system in 1972; it was based on personal correspondence, information from MEDLINE and international citation indexes searches. The grading system was published in 1976 and since has been cited over 650 times.[ citation needed ]

The committee's directive was to standardise the definition of terms used in reporting patients who had coronary artery disease and coronary artery bypass graft surgery. The purpose of defining a scale for the severity of exertional angina was to evaluate the efficacy of medical and surgical therapy by comparing the patient’s status before and after therapeutic interventions. It was expected that a four-grade instead of a three-grade system would result in a greater discriminative power that would ensure better reproducibility. The grading scale was derived and modelled using some criteria from the New York Heart Association Functional Classification and the American Medical Association classes of organic heart diseases. The severity of angina on exertion was categorised by independent observers who detailed threshold activities for each level and noted the changes over time (different stages of angina pectoris are based on the level of difficulties patients have with carrying out ordinary activities; ordinary activities includes walking and climbing the stairs). [6]

Epidemiology

Angina is not classified as a disease in itself, it refers to a person having chest pain with coronary heart disease, due to the lack of oxygen their myocardium as the presumed cause. [12] A high mortality rate is associated with coronary heart disease. It is the leading cause of death in the United States, accounting for 26.6% of all death in 2005. [13] Another study in the United States estimates that coronary heart disease has the greatest prevalence amongst people aged 65 years or over (19.8% in 2010), [14] followed by people who are aged between 45-64 (with a prevalence of 7.1%). The United Kingdom also has a high mortality rate with 16% of all male deaths and 10% of all female deaths being attributable to coronary heart disease. [15] However, it is worth noting that the mortality rate of coronary heart disease has been in steady decline since its peak in the 1960s, in contrast to the morbidity trend which has increased with increasing rates of revascularisation. [13]

Economic burden

Chronic angina is often associated with substantial economic burden to the society, both in terms of healthcare expenditure and lost productivity. [16]

According to a network meta-analysis of cost-effectiveness studies the mean weight cost of coronary artery bypass grafting per patient is $27,003 and $28,670 at one and three years respectively, whereas three years’ worth of medical treatment costs $13,864 per patient. [17] The mean weight cost per patient undergoing percutaneous coronary intervention without stent (PTCA) after three years of follow up is $14,277. The expenditure increases significantly when patients require additional revascularization during follow-up.

In South Asian countries such as India, Bangladesh, Nepal and Sri Lanka, one aspect of healthcare expenditure on angina-affected households is out-of-pocket spending on medicine and primary outpatient care. [18] This would point to greater reliance on trading household assets to finance health services, which have long-term implications on the affected households.

See also

Related Research Articles

<span class="mw-page-title-main">Coronary artery disease</span> Reduction of blood flow to the heart muscle due to plaque buildup in the hearts arteries

Coronary artery disease (CAD), also called coronary heart disease (CHD), ischemic heart disease (IHD), myocardial ischemia, or simply heart disease, involves the reduction of blood flow to the heart muscle due to build-up of atherosclerotic plaque in the arteries of the heart. It is the most common of the cardiovascular diseases. Types include stable angina, unstable angina, and myocardial infarction. A common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw. Occasionally it may feel like heartburn. Usually symptoms occur with exercise or emotional stress, last less than a few minutes, and improve with rest. Shortness of breath may also occur and sometimes no symptoms are present. In many cases, the first sign is a heart attack. Other complications include heart failure or an abnormal heartbeat.

<span class="mw-page-title-main">Angina</span> Chest discomfort due to not enough blood flow to heart muscle

Angina, also known as angina pectoris, is chest pain or pressure, usually caused by insufficient blood flow to the heart muscle (myocardium). It is most commonly a symptom of coronary artery disease.

An antiplatelet drug (antiaggregant), also known as a platelet agglutination inhibitor or platelet aggregation inhibitor, is a member of a class of pharmaceuticals that decrease platelet aggregation and inhibit thrombus formation. They are effective in the arterial circulation where classical Vitamin K antagonist anticoagulants have minimal effect.

<span class="mw-page-title-main">Coronary artery bypass surgery</span> Surgical procedure to restore normal blood flow to an obstructed coronary artery

Coronary artery bypass surgery, also known as coronary artery bypass graft, is a surgical procedure to treat coronary artery disease (CAD), the buildup of plaques in the arteries of the heart. It can relieve chest pain caused by CAD, slow the progression of CAD, and increase life expectancy. It aims to bypass narrowings in heart arteries by using arteries or veins harvested from other parts of the body, thus restoring adequate blood supply to the previously ischemic heart.

<span class="mw-page-title-main">Interventional cardiology</span>

Interventional cardiology is a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Andreas Gruentzig is considered the father of interventional cardiology after the development of angioplasty by interventional radiologist Charles Dotter.

<span class="mw-page-title-main">Acute coronary syndrome</span> Medical condition

Acute coronary syndrome (ACS) is a syndrome due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is centrally located pressure-like chest pain, often radiating to the left shoulder or angle of the jaw, and associated with nausea and sweating. Many people with acute coronary syndromes present with symptoms other than chest pain, particularly women, older people, and people with diabetes mellitus.

<span class="mw-page-title-main">Variant angina</span> Medical condition

Variant angina, also known as Prinzmetal angina,vasospastic angina, angina inversa, coronary vessel spasm, or coronary artery vasospasm, is a syndrome typically consisting of angina. Variant angina differs from stable angina in that it commonly occurs in individuals who are at rest or even asleep, whereas stable angina is generally triggered by exertion or intense exercise. Variant angina is caused by vasospasm, a narrowing of the coronary arteries due to contraction of the heart's smooth muscle tissue in the vessel walls. In comparison, stable angina is caused by the permanent occlusion of these vessels by atherosclerosis, which is the buildup of fatty plaque and hardening of the arteries.

<span class="mw-page-title-main">Unstable angina</span> Medical condition

Unstable angina is a type of angina pectoris that is irregular or more easily provoked. It is classified as a type of acute coronary syndrome.

<span class="mw-page-title-main">Percutaneous coronary intervention</span> Medical techniques used to manage coronary occlusion

Percutaneous coronary intervention (PCI) is a minimally invasive non-surgical procedure used to treat narrowing of the coronary arteries of the heart found in coronary artery disease. The procedure is used to place and deploy coronary stents, a permanent wire-meshed tube, to open narrowed coronary arteries. PCI is considered 'non-surgical' as it uses a small hole in a peripheral artery (leg/arm) to gain access to the arterial system, an equivalent surgical procedure would involve the opening of the chest wall to gain access to the heart area. The term 'coronary angioplasty with stent' is synonymous with PCI. The procedure visualises the blood vessels via fluoroscopic imaging and contrast dyes. PCI is performed by an interventional cardiologists in a catheterization laboratory setting.

<span class="mw-page-title-main">Ivabradine</span> Heart medication

Ivabradine, sold under the brand name Procoralan among others, is a medication, which is a pacemaker current (If) inhibitor, used for the symptomatic management of heart-related chest pain and heart failure. Patients who qualify for use of Ivabradine for coronary heart failure are patients who have symptomatic heart failure, with reduced ejection volume, and heart rate at least 70 bpm, and the condition not able to be fully managed by beta blockers.

<span class="mw-page-title-main">Drug-eluting stent</span> Medical stent that releases drug

A drug-eluting stent (DES) is a thin tube that is used to treat narrowed arteries in medical procedures. It releases drugs to prevent the growth of scar tissue and reduce the risk of stent restenosis, which is the narrowing of the stented area of an artery after treatment. A drug-eluting stent is different from other types of stents because it has a coating that delivers medication directly to the arterial wall. A DES is often made of metal alloys and can be inserted into blocked or narrowed arteries through a catheter placed in a peripheral artery, such as in the arm or leg. DES is fully integrated with a catheter delivery system and is viewed as one integrated medical device.

<span class="mw-page-title-main">Bivalirudin</span> Anticoagulant drug

Bivalirudin (Bivalitroban), sold under the brand names Angiomax and Angiox and manufactured by The Medicines Company, is a specific and reversible direct thrombin inhibitor (DTI).

Coronary vasospasm refers to when a coronary artery suddenly undergoes either complete or sub-total temporary occlusion.

Postperfusion syndrome, also known as "pumphead", is a constellation of neurocognitive impairments attributed to cardiopulmonary bypass (CPB) during cardiac surgery. Symptoms of postperfusion syndrome are subtle and include defects associated with attention, concentration, short-term memory, fine motor function, and speed of mental and motor responses. Studies have shown a high incidence of neurocognitive deficit soon after surgery, but the deficits are often transient with no permanent neurological impairment.

<span class="mw-page-title-main">Off-pump coronary artery bypass</span>

Off-pump coronary artery bypass or "beating heart" surgery is a form of coronary artery bypass graft (CABG) surgery performed without cardiopulmonary bypass as a treatment for coronary heart disease. It was primarily developed in the early 1990s by Dr. Amano Atsushi. Historically, during bypass surgeries, the heart is stopped and a heart-lung machine takes over the work of the heart and lungs. When a cardiac surgeon chooses to perform the CABG procedure off-pump, also known as OPCAB, the heart is still beating while the graft attachments are made to bypass a blockage.

<span class="mw-page-title-main">Coronary stent</span> Medical stent implanted into coronary arteries

A coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in patients suffering from coronary heart disease. The vast majority of stents used in modern interventional cardiology are drug-eluting stents (DES) It is used in a medical procedure called percutaneous coronary intervention (PCI). Coronary stents are divided into two broad types - drug-eluting and bare metal stents, as of 2023 drug-eluting stents were used in more than 90% of all PCI procedures. Stents reduce angina and have been shown to improve survival and decrease adverse events after a patient has suffered a heart attack - medically termed an acute myocardial infarction.

<span class="mw-page-title-main">Coronary ischemia</span> Medical condition

Coronary ischemia, myocardial ischemia, or cardiac ischemia, is a medical term for a reduced blood flow in the coronary circulation through the coronary arteries. Coronary ischemia is linked to heart disease, and heart attacks. Coronary arteries deliver oxygen-rich blood to the heart muscle. Reduced blood flow to the heart associated with coronary ischemia can result in inadequate oxygen supply to the heart muscle. When oxygen supply to the heart is unable to keep up with oxygen demand from the muscle, the result is the characteristic symptoms of coronary ischemia, the most common of which is chest pain. Chest pain due to coronary ischemia commonly radiates to the arm or neck. Certain individuals such as women, diabetics, and the elderly may present with more varied symptoms. If blood flow through the coronary arteries is stopped completely, cardiac muscle cells may die, known as a myocardial infarction, or heart attack.

Minimally invasive cardiac surgery, also known as MICS CABG or the McGinn technique is heart surgery performed through several small incisions instead of the traditional open-heart surgery that requires a median sternotomy approach. MICS CABG is a beating-heart multi-vessel procedure performed under direct vision through an anterolateral mini-thoracotomy.

<span class="mw-page-title-main">Reperfusion therapy</span> Restoring blood flow post-heart attack

Reperfusion therapy is a medical treatment to restore blood flow, either through or around, blocked arteries, typically after a heart attack. Reperfusion therapy includes drugs and surgery. The drugs are thrombolytics and fibrinolytics used in a process called thrombolysis. Surgeries performed may be minimally-invasive endovascular procedures such as a percutaneous coronary intervention (PCI), which involves coronary angioplasty. The angioplasty uses the insertion of a balloon and/or stents to open up the artery. Other surgeries performed are the more invasive bypass surgeries that graft arteries around blockages.

<span class="mw-page-title-main">Ischemic cardiomyopathy</span> Medical condition

Ischemic cardiomyopathy is a type of cardiomyopathy caused by a narrowing of the coronary arteries which supply blood to the heart. Typically, patients with ischemic cardiomyopathy have a history of acute myocardial infarction, however, it may occur in patients with coronary artery disease, but without a past history of acute myocardial infarction. This cardiomyopathy is one of the leading causes of sudden cardiac death. The adjective ischemic means characteristic of, or accompanied by, ischemia — local anemia due to mechanical obstruction of the blood supply.

References

  1. 1 2 NHS Choices (2015-04-29). "Angina - Treatment - NHS Choices". www.nhs.uk. Retrieved 2016-11-12.
  2. ↑ NHS Choices (2015-11-09). "Coronary angioplasty and stent insertion - NHS Choices". www.nhs.uk. Retrieved 2016-11-12.
  3. ↑ "Stable angina: management | Key-priorities-for-implementation | Guidance and guidelines | Clinical guideline [CG126] | NICE". www.nice.org.uk. August 2016. Retrieved 2016-11-12.
  4. ↑ Rimmerman, Curtis M (February 2013). "Coronary Artery Disease". www.clevelandclinicmeded.com. Retrieved 2016-11-12.
  5. ↑ Serruys, Patrick W.; Morice, Marie-Claude; Kappetein, A. Pieter; Colombo, Antonio; Holmes, David R.; Mack, Michael J.; Ståhle, Elisabeth; Feldman, Ted E.; van den Brand, Marcel (2009-03-05). "Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease". New England Journal of Medicine. 360 (10): 961–972. doi:10.1056/NEJMoa0804626. hdl: 2437/95138 . ISSN   0028-4793. PMID   19228612.
  6. 1 2 3 4 Campeau, Lucien (2002). "The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later". The Canadian Journal of Cardiology. Can J Cardiol. 18 (4): 371–379. PMID   11992130 . Retrieved 2016-11-12.
  7. ↑ Kaul, Padma; Naylor, C. David; Armstrong, Paul W.; Mark, Daniel B.; Theroux, Pierre; Dagenais, Gilles R. (2009-07-01). "Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification". The Canadian Journal of Cardiology. 25 (7): e225–231. doi:10.1016/s0828-282x(09)70506-9. ISSN   1916-7075. PMC   2723031 . PMID   19584977.
  8. ↑ Smith, David; Toff, William; Joy, Michael; Dowdall, Nigel; Johnston, Raymond; Clark, Liz; Gibbs, Simon; Boon, Nick; Hackett, David (2010-08-01). "Fitness to fly for passengers with cardiovascular disease". Heart. 96 (Suppl 2): ii1–ii16. doi:10.1136/hrt.2010.203091. ISSN   1468-201X. PMID   20644218. S2CID   16420591.
  9. ↑ "Canadian Cardiovascular Society grading of angina pectoris" (PDF). Canadian Cardiovascular Society. Archived from the original (PDF) on September 23, 2015. Retrieved Nov 12, 2016.
  10. ↑ Gray, Rosaire; Pack, Louise (2010-12-16). Cardiovascular Disease in the Elderly. OUP Oxford. ISBN   9780199570591.
  11. ↑ Canadian Cardiovascular Society. "CCS Mission". www.ccs.ca. Retrieved 2016-11-12.
  12. ↑ American Heart Association (2016-10-11). "Angina (Chest Pain)". www.heart.org. Retrieved 2016-11-12.
  13. 1 2 Bittner, Vera (2008-03-25). "Angina Pectoris". Circulation. 117 (12): 1505–1507. doi: 10.1161/CIRCULATIONAHA.108.764217 . ISSN   0009-7322. PMID   18362242.
  14. ↑ "Prevalence of Coronary Heart Disease- United States, 2006-2010". Centers for Disease Control and Prevention. 60 (40): 1377–1381.
  15. ↑ Bhatnagar, Prachi; Wickramasinghe, Kremlin; Williams, Julianne; Rayner, Mike; Townsend, Nick (2015-06-03). "The epidemiology of cardiovascular disease in the UK 2014". Heart. 101 (15): heartjnl–2015–307516. doi:10.1136/heartjnl-2015-307516. ISSN   1468-201X. PMC   4515998 . PMID   26041770.
  16. ↑ Reynolds, Matthew W.; Frame, Diana; Scheye, Rachel; Rose, M. Evelyn; George, Samuel; Watson, Jennifer B.; Hlatky, Mark A. (2004-10-01). "A systematic review of the economic burden of chronic angina". The American Journal of Managed Care. 10 (11 Suppl): S347–357. ISSN   1088-0224. PMID   15603244.
  17. ↑ Caruba, Thibaut; Katsahian, Sandrine; Schramm, Catherine; Nelson, Anaïs Charles; Durieux, Pierre; Bégué, Dominique; Juillière, Yves; Dubourg, Olivier; Danchin, Nicolas (2014-06-04). "Treatment for Stable Coronary Artery Disease: A Network Meta-Analysis of Cost-Effectiveness Studies". PLOS ONE. 9 (6): e98371. Bibcode:2014PLoSO...998371C. doi: 10.1371/journal.pone.0098371 . ISSN   1932-6203. PMC   4045726 . PMID   24896266.
  18. ↑ Alam, Khurshid; Mahal, Ajay (2014-01-01). "The economic burden of angina on households in South Asia". BMC Public Health. 14: 179. doi: 10.1186/1471-2458-14-179 . ISSN   1471-2458. PMC   3930925 . PMID   24548585.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.